REMINYL Prolonged Release caps 8 mg 28 pce

7680567540053 CH-56754 N06DA04 01.99.0.

Reimbursement limitations:

THERAPIEBEG

En début de thérapie, application par ex. d'un test minimental.
Première évaluation intermédiaire après trois …

REMINYL Prolonged Release caps 8 mg 28 pce
REMINYL Prolonged Release caps 8 mg 28 pce
REMINYL Prolonged Release caps 8 mg 28 pce
1 / 3
google

Details

Product number
5675401
CPT
-
Packaging group
28
Unit
Kapsel(n)
Composition
galantaminum 8 mg ut galantamini hydrobromidum, sacchari sphaerae corresp. saccharum 50.9-58.21 mg, ethylcellulosum, hypromellosum, diethylis phthalas, macrogolum 400, Kapselhülle: gelatina, E 171, Drucktinte: lacca, propylenglycolum, E 172 (nigrum), pro capsula.

Articles (1)

Reminyl PR 8 mg, Kapseln
Kapseln
28
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
29/04/2025
Patient information leaflet
Français
29/04/2025
Patient information leaflet
Italien
29/04/2025
Professional SmPC
Allemand
29/04/2025
Professional SmPC
Français
29/04/2025
Professional SmPC
Italien
29/04/2025

Detailed composition

Substance Quantity Type Category
(N/A)
8.0 MG Substance Wirkstoff (Principe actif)
(N/A)
- Substance WIZUS
(N/A)
- Substance HNIDK
(N/A)
- Substance HBESI
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance Hilfsstoff ohne Deklarationspflicht (Excipient sans obligation de déclaration)
(N/A)
- Substance HNIDK
(N/A)
- Substance FNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance Hilfsstoff ohne Deklarationspflicht (Excipient sans obligation de déclaration)
(N/A)
- Substance FTODK

Reimbursement information

Public price
CHF 63.10
Specialties list
Yes
Generic
No

Reimbursement limitation

SL addition date: 01/07/2005

Authorization holder

Essential Pharma Switzerland GmbH

6300 Zug

Authorization information

Swissmedic authorization number
56754
Drug name
Reminyl PR, Kapseln
Galenic form
KAHA
ATC Code
N06DA04
Authorization status
Z
Dispensation category
B
First authorization
09/06/2005
Authorization expiration date
31/12/9999
IT number
01.99.0.
Domain
Human medicine
Field of application
Leichte bis mittelschwere Demenz vom Alzheimer Typ

Packaging details

Description (FR)
REMINYL Prolonged Release caps 8 mg 28 pce
Description (DE)
REMINYL Prolonged Release Kaps 8 mg 28 Stk
Market launch
09/06/2005
Narcotic (BTM)
No

Available generics

Galantamin SR Zentiva, Retardkapseln
CHF 59.10
View
Galantamin SR Zentiva, Retardkapseln
CHF 59.10
View
Galantamin SR Zentiva, Retardkapseln
CHF 59.10
View

Other packaging sizes

REMINYL Prolonged Release caps 16 mg 28 pce
28 KAP
View
REMINYL Prolonged Release caps 24 mg 28 pce
28 KAP
View